Lilly Alzheimer’s Drug Can Save Dismal Year for Pharma

Upcoming Alzheimer’s disease results from Eli Lilly will have major impact on biotech and pharma stocks.

Popular Posts


(Visited 8 times, 1 visits today)

Vote on this story -->>>

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami